{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T00:18:36Z","timestamp":1773533916307,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T00:00:00Z","timestamp":1497657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T00:00:00Z","timestamp":1497657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["F32DK096765"],"award-info":[{"award-number":["F32DK096765"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK103972"],"award-info":[{"award-number":["K23DK103972"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32DK007357"],"award-info":[{"award-number":["T32DK007357"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR000122"],"award-info":[{"award-number":["KL2TR000122"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001259","name":"National Kidney Foundation","doi-asserted-by":"publisher","award":["Satellite Dialysis Clinical Investigator Award"],"award-info":[{"award-number":["Satellite Dialysis Clinical Investigator Award"]}],"id":[{"id":"10.13039\/100001259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12882-017-0616-4","type":"journal-article","created":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T08:29:40Z","timestamp":1497688180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study"],"prefix":"10.1186","volume":"18","author":[{"given":"Jenny I.","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali B.","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sitaram","family":"Vangala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satvinder K.","family":"Dhaliwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang C.","family":"Winkelmayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,17]]},"reference":[{"issue":"10","key":"616_CR1","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1681\/ASN.V12102158","volume":"12","author":"JM Bargman","year":"2001","unstructured":"Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001;12(10):2158\u201362.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"616_CR2","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.V1351307","volume":"13","author":"R Paniagua","year":"2002","unstructured":"Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002;13(5):1307\u201320.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"616_CR3","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0272-6386(03)00362-7","volume":"41","author":"F Termorshuizen","year":"2003","unstructured":"Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative study on the adequacy of dialysis (NECOSAD )-2. Am J Kidney Dis. 2003;41(6):1293\u2013302.","journal-title":"Am J Kidney Dis"},{"key":"616_CR4","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1038\/sj.ki.5002600","volume":"108","author":"B Marron","year":"2008","unstructured":"Marron B, Remon C, Perez-Fontan M, Quiros P, Ortiz A. Benefits of preserving residual renal function in peritoneal dialysis. Kidney Int Suppl. 2008;108:S42\u201351.","journal-title":"Kidney Int Suppl"},{"issue":"11","key":"616_CR5","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1093\/ndt\/16.11.2207","volume":"16","author":"MK Menon","year":"2001","unstructured":"Menon MK, Naimark DM, Bargman JM, Vas SI, Oreopoulos DG. Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant. 2001;16(11):2207\u201313.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"616_CR6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1046\/j.1523-1755.2002.00471.x","volume":"62","author":"AY Wang","year":"2002","unstructured":"Wang AY, Wang M, Woo J, Law MC, Chow KM, Li PK, et al. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int. 2002;62(2):639\u201347.","journal-title":"Kidney Int"},{"issue":"3","key":"616_CR7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/ndt\/15.3.396","volume":"15","author":"T Suda","year":"2000","unstructured":"Suda T, Hiroshige K, Ohta T, Watanabe Y, Iwamoto M, Kanegae K, et al. The contribution of residual renal function to overall nutritional status in chronic haemodialysis patients. Nephrol Dial Transplant. 2000;15(3):396\u2013401.","journal-title":"Nephrol Dial Transplant"},{"key":"616_CR8","first-page":"189","volume":"18","author":"DE Page","year":"2002","unstructured":"Page DE, Knoll GA, Cheung V. The relationship between residual renal function, protein catabolic rate, and phosphate and magnesium levels in peritoneal dialysis patients. Adv Perit Dial. 2002;18:189\u201391.","journal-title":"Adv Perit Dial"},{"issue":"8","key":"616_CR9","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1097\/01.ASN.0000135053.98172.D6","volume":"15","author":"AY Wang","year":"2004","unstructured":"Wang AY, Wang M, Woo J, Lam CW, Lui SF, Li PK, et al. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol. 2004;15(8):2186\u201394.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"616_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.7326\/0003-4819-139-2-200307150-00010","volume":"139","author":"PK Li","year":"2003","unstructured":"Li PK, Chow KM, Wong TY, Leung CB, Szeto CC. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study. Ann Intern Med. 2003;139(2):105\u201312.","journal-title":"Ann Intern Med"},{"issue":"6","key":"616_CR11","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1053\/j.ajkd.2004.01.019","volume":"43","author":"H Suzuki","year":"2004","unstructured":"Suzuki H, Kanno Y, Sugahara S, Okada H, Nakamoto H. Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD. Am J Kidney Dis. 2004;43(6):1056\u201364.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"616_CR12","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1377\/hlthaff.2014.1192","volume":"34","author":"D Ansell","year":"2015","unstructured":"Ansell D, Pallok K, Guzman MD, Flores M, Oberholzer J. Illinois law opens door to kidney transplants for undocumented immigrants. Health Aff (Project Hope). 2015;34(5):781\u20137.","journal-title":"Health Aff (Project Hope)"},{"issue":"1","key":"616_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3747\/pdi.2009.00088","volume":"31","author":"I Kolesnyk","year":"2011","unstructured":"Kolesnyk I, Noordzij M, Dekker FW, Boeschoten EW, Krediet RT. Treatment with Angiotensin ii inhibitors and residual renal function in peritoneal dialysis patients. Perit Dial Int. 2011;31(1):53\u20139.","journal-title":"Perit Dial Int"},{"issue":"12","key":"616_CR14","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1681\/ASN.2012060554","volume":"23","author":"TI Chang","year":"2012","unstructured":"Chang TI, Shilane D, Kazi DS, Montez-Rath ME, Hlatky MA, Winkelmayer WC. Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD. J Am Soc Nephrol. 2012;23(12):2042\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"25","key":"616_CR15","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083\u2013107.","journal-title":"Stat Med"},{"issue":"5","key":"616_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","volume":"11","author":"JM Robins","year":"2000","unstructured":"Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11(5):550\u201360.","journal-title":"Epidemiology"},{"issue":"4","key":"616_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0895-4356(00)00321-8","volume":"54","author":"ST Normand","year":"2001","unstructured":"Normand ST, Landrum MB, Guadagnoli E, Ayanian JZ, Ryan TJ, Cleary PD, et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol. 2001;54(4):387\u201398.","journal-title":"J Clin Epidemiol"},{"key":"616_CR18","first-page":"CD009120","volume":"6","author":"L Zhang","year":"2014","unstructured":"Zhang L, Zeng X, Fu P, Wu HM. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients. Cochrane Database Syst Rev. 2014;6:CD009120.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"616_CR19","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/089686080302300311","volume":"23","author":"DW Johnson","year":"2003","unstructured":"Johnson DW, Mudge DW, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, et al. Predictors of decline of residual renal function in new peritoneal dialysis patients. Perit Dial Int. 2003;23(3):276\u201383.","journal-title":"Perit Dial Int"},{"issue":"3","key":"616_CR20","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.V113556","volume":"11","author":"LM Moist","year":"2000","unstructured":"Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11(3):556\u201364.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"616_CR21","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1093\/ndt\/gfn321","volume":"23","author":"W Fang","year":"2008","unstructured":"Fang W, Oreopoulos DG, Bargman JM. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis. Nephrol Dial Transplant. 2008;23(11):3704\u201310.","journal-title":"Nephrol Dial Transplant"},{"key":"616_CR22","doi-asserted-by":"crossref","unstructured":"Shen JI, Saxena AB, Montez-Rath ME, Winkelmayer WC. Angiotensin-converting enzyme inhibitor\/angiotensin receptor blocker use and cardiovascular outcomes in patients inititiating peritoneal dialysis. Nephrol Dial Transplant. 2016. In Press.","DOI":"10.1093\/ndt\/gfw053"},{"issue":"9","key":"616_CR23","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/aje\/kwg231","volume":"158","author":"WA Ray","year":"2003","unstructured":"Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003;158(9):915\u201320.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"616_CR24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.arth.2015.09.003","volume":"31","author":"PK Cavanaugh","year":"2016","unstructured":"Cavanaugh PK, Chen AF, Rasouli MR, Post ZD, Orozco FR, Ong AC. Complications and mortality in chronic renal failure patients undergoing total joint arthroplasty: a comparison between dialysis and renal transplant patients. J Arthroplast. 2016;31(2):465\u201372.","journal-title":"J Arthroplast"},{"key":"616_CR25","unstructured":"Census Bureau Regions and Divisions with State FIPS Codes. [ https:\/\/www.census.gov\/geographies\/reference-files\/2012\/demo\/popest\/2012-geocodes-all.html ]. Accessed 5 Jan 2012."}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0616-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-017-0616-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0616-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T20:27:20Z","timestamp":1659126440000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-017-0616-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,17]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["616"],"URL":"https:\/\/doi.org\/10.1186\/s12882-017-0616-4","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,17]]},"assertion":[{"value":"31 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"196"}}